4 years ago

Oxford Endovascular Raises £7.2M to Advance Treatment for Brain Aneurysms

  • Oxford Endovascular, a UK-based medtech company, has raised £7.2 million in a Series A funding round led by Vulpes Investment Management

  • The company will use the funding to complete development work and gain first-in-human data through an early feasibility clinical study for its micro stent, OxiFlow

  • The device aims to treat brain aneurysms, a condition that affects 1 in 50 people.

      • ProblemHealthcare

      "Preventing brain haemorrhage by curing brain aneurysms, a condition that affects 1 in 50 people."

      Solution

      "Developing a micro stent called OxiFlow, utilising ‘Origami’ engineering, which can be inserted into the brain blood vessels via minimally invasive groin access, allowing for more accurate and safer treatment of brain aneurysms."

      Covered on